Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the ...

They have already taken the weight-loss sector by storm - now the blockbuster drugs Ozempic and Mounjaro could do the same ...

Novo Nordisk said it's ending its collaboration due to concerns with Hims & Hers the company's sales and promotion of cheap ...

Hims & Hers stock plummeted around 30% in early trading Monday after Novo Nordisk announced it was ending a collaboration to ...

In a first round human trial slimmers in Sweden taking the new drug-currently known as ATR-258-found they burnt fat yet ...

The mass rollout of weight loss jabs such as Mounjaro on the NHS in England will begin today as GPs are allowed to prescribe the drugs for the ...

Cancer patients must speak to their doctor before taking weight-loss jabs, a British charity has warned, amid a rise in people seeking help over whether they can take them.Macmillan Cancer Support ...

Shares in Novo Nordisk fell as much as 3.5 per cent on Monday after detailed trial data on its experimental obesity drug ...

Novo Nordisk cut off Hims & Hers Health from selling lower-priced Wegovy on Monday morning, but its explanation for the ...

U.S. equities were higher at midday as concerns oil prices would spike because of the U.S. attack on Iran diminished.